Nigerian-born doctor, Chibawanye Ene wins ‘brain tumor research’ award in US

Chibawanye Ene, a Nigerian-American doctor, has won the 2019 Ronald L. Bittner Award for his research on brain tumour; a research paper that could be the key to fighting one of the deadliest cancer.

Chibawanye Ene, 37, hails from Akpugo, in the western local government area of ​​Nkanu, Enugu State. He received the award at the annual scientific meeting of the American Association of Neurological Surgeons (AANS), held April 13-17 in San Diego, United States.

According to the Applied Radiation Oncology, a quarterly journal on cancer, Chibawanye Ene’s work titled: “Anti-PD-L1 Immunotherapy Enhances Radiation-induced Abscopal Response in Glioblastoma”, has been hailed for finding better treatment options for deadly brain tumours. His paper shows that “radiation combined with Anti PD L1 therapy induces an immunological response to unirradiated glioblastoma”.

“The researchers are currently optimizing other treatment combinations that could also be readily assessed in phase I human clinical trials,” the journal added.

Glioblastoma, also known as GBM, is the deadliest form of cancer that begins within the brain or spinal cord with symptoms ranging from headaches to personality changes, nausea, and incontinence. The median survival for adults with standard treatment is between 11–15 months.

Immunotherapy is a type of cancer treatment that helps the immune system fight cancer, although it has been largely unsuccessful in the treatment of Glioblastoma. This explains why Dr Ene’s paper on Immunotherapy (a type of cancer treatment) has made him the recipient of the 2019 Ronald L. Bittner Award.

Nigerians doing big things abroad

ALSO READ: Tobechukwu Phillips Breaks American School’s 125-year Academic History

Last week, a Nigerian teenager broke an American school’s 125-year old record as when she became the first black valedictorian.

Tobechukwu “Tobi” Phillips graduated at the top of her class at the Alvin High School in Texas.

38,876 total views, 1 views today

Share this:
Share On Facebook
Share On Twitter
Share On Linkedin
Share On Pinterest

Comments are closed.